[Schedule for evaluation of the deficit syndrome in schizophrenia: Schedule for Deficit Syndrome (SDS) (Kirkpatrick et al.). Importance pertinence of the SDS. Introduction of the French version].

No abstract is available for this paper.

• Publication year

  1994

• Venue

  L'Encephale

• Publication date

  1994-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 7988405
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural abnormalities in deficit and nondeficit schizophrenia.

  1993cited by this paper
• Case identification and stability of the deficit syndrome of schizophrenia.

  1993cited by this paper
• Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome.

  1992cited by this paper
• [Plasma homovanillic acid level inpatients with deficit forms of schizophrenics].

  1991cited by this paper
• The Neural Basis of the Deficit Syndrome of Schizophrenia

  1990cited by this paper
• Clinical correlates of the deficit syndrome of schizophrenia.

  1990cited by this paper
• Anhedonia and the deficit syndrome of schizophrenia.

  1990cited by this paper
• The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

  1989cited by this paper
• Oculomotor abnormalities and their clinical correlates in schizophrenia.

  1989cited by this paper
• A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.

  1988cited by this paper
• Deficit and nondeficit forms of schizophrenia: the concept.

  1988cited by this paper
• Deficit and nondeficit forms of schizophrenia: neuropsychological evaluation.

  1987cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Preliminary evidence of reduced combined output of dopamine and its metabolites in chronic schizophrenia.

  1987cited by this paper
• Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence.

  1986cited by this paper
• Negative v positive schizophrenia. Definition and validation.

  1982cited by this paper
• Molecular pathology of schizophrenia: more than one disease process?

  1980cited by this paper
• Central dopamine turnover in schizophrenic syndromes.

  1974cited by this paper

• Évolution de la symptomatologie négative chez les patients schizophrènes hospitalisés

  2019cites this paper
• Current developments and challenges in the assessment of negative symptoms.

  2017cites this paper
• [Scale for assessing negative symptoms in schizophrenia: A systematic review].

  2016cites this paper
• Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

  2016cites this paper
• Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.

  2015cites this paper
• Distinct Episodic Verbal Memory Profiles in Schizophrenia

  2013cites this paper
• Impaired decision making in schizophrenia and orbitofrontal cortex lesion patients.

  2010influential citation
• Impaired smooth pursuit in schizophrenia results from prediction impairment only.

  2010cites this paper
• [Adaptation and validation into Spanish of Schedule for the Deficit Syndrome].

  2007cites this paper
• Adaptación y validación en castellano del Inventario para la Esquizofrenia Deficitaria

  2007cites this paper
• Évaluation comparative de la qualité de vie de patients schizophrènes traités par neuroleptiques classiques et neuroleptiques atypiques : résultats d’une étude transversale

  2006cites this paper
• [Comparative evaluation of quality of life in patients with schizophrenia treated with conventional versus atypical neuroleptics: results of a transversal study].

  2006cites this paper
• Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms.

  2005cites this paper
• Quality of life in schizophrenics with and without the deficit syndrome

  2004cites this paper
• Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria.

  2002cites this paper
• SPECT imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome.

  2002cites this paper
• Cognitive patterns in subtypes of schizophrenia

  2002cites this paper
• Sinistrality in subtypes of schizophrenia

  2002cites this paper
• Concordance of deficit and non-deficit subtypes in siblings affected with schizophrenia.

  2001cites this paper
• Subtyping schizophrenia according to outcome or severity: a search for homogeneous subgroups.

  2001cites this paper
• Saccadic and smooth-pursuit eye movements in deficit and non-deficit schizophrenia.

  2001cites this paper
• Frecuencia de la apolipoproteína E-ɛ4, en la esquizofrenia de déficit

  2000cites this paper
• Objective and Subjective Extrapyramidal Side Effects in Schizophrenia: Their Relationships with Negative and Depressive Symptoms

  2000cites this paper
• Anhedonia in the Deficit Syndrome of Schizophrenia

  1999cites this paper
• Apolipoprotein E-ε4 frequency in deficit schizophrenia

  1999cites this paper
• Apolipoprotein E-varepsilon4 frequency in deficit schizophrenia.

  1999cites this paper
• [Comorbidity, anxiety disorders and schizophrenia: epidemiological and clinical aspects].

  1999cites this paper
• Family history and obstetric complications in deficit and non-deficit schizophrenia: preliminary results

  1998cites this paper
• Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and nondeficit forms of schizophrenia.

  1998cites this paper
• [Syndromic and diagnostic heterogeneity of schizophrenia].

  1997cites this paper
• [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].

  1997cites this paper
• [Alexithymia in negative symptom and non-negative symptom schizophrenia].

  1997cites this paper
• [Deficit: the value and difficulty of defining the primary or secondary character of observed symptoms].

  1996cites this paper
• [Identification by typological analysis of distinct groups of schizophrenic patients. Applicability of a disorganized schizophrenia subtype].

  1996cites this paper
• [Methodological constraints in evaluating anti-deficit effects].

  1996cites this paper
• Identifying subtypes of schizophrenia by cluster analyses.

  1995cites this paper
• [Depressive symptoms and negative symptoms during schizophrenia].

  1995cites this paper
• A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia.

  1994cites this paper